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Our internal organs (or, more precisely, organ systems) do not operate in isolation from
one another. Consequently, dysfunction in one organ system often affects others, sometimes
exacerbating the original dysfunction. For instance, pneumonia (an infection of the res-
piratory system) can result in insufficient oxygen to the kidneys, reducing their ability to
filter wastes from the blood, and resulting in abnormally high levels of waste in the blood5
[9, 17, 41, 28]. This, in turn, can affect both cardiac and respiratory function, leading to an
even lower oxygen supply for the kidneys, so kidney function is further compromised, and
the patient rapidly declines from an unseen negative feedback loop operating inside them
[10, 25]. In the medical community, this is known as sequential organ failure (SOF), and
this can arise from trauma, serious infection (leading to sepsis), or in a “regular” illness,10
when comorbidities (i.e. pre-existing health conditions) are present [31]. In intensive care
units (ICUs), healthcare professionals routinely use scoring systems like the Sequential Organ
Failure Assessment (SOFA) to predict the likelihood of death in a patient with SOF [22].
It is not an exaggeration to describe the human circulatory (i.e. cardiovascular) system as
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the body’s main transport system. This system, consisting of the heart and all blood vessels,15
is the main physical interconnection between the main organ systems, as it carries nutrients
and wastes from one organ to another, linking these systems into a single complex network.
Dr. Lester Caudill’s research lab is actively engaged in developing a mathematical model of
this organ system network, with the long-term goal of investigating treatment options (via
model simulations) for medical conditions (especially pneumonia and sepsis [11]) that lead20
to SOF.
Logically, a model of this network should begin with the circulatory system as its foun-
dation. At its core, an acceptable (for our purposes) mathematical model of the circulatory
system must meet certain design criteria:
• reflect the key functionality of the system (e.g. beating heart, pressure-driven blood25
circulation).
• include the ability of our system model to transport nutrients and wastes through the
system (including a second organ system) via blood flow dynamics.
• be mathematically simple enough to be expandable to include models of other organ
systems.30
This research focuses on developing a circulatory system differential equations model that
meets these design criteria.
This thesis is organized as follows: Chapter 1 provides the physiological background of the
circulatory system and its function, which will serve as a basis for our model. We develop and
present our model in Chapter 2. In Chapter 3, we conduct some model validation via several35
numerical proof-of-concept demonstrations. Chapter 4 presents a strategy for modeling
the transport of substances via our model’s “blood,” as well as a potential application to




Over the years, various approaches to modeling the circulatory system have been pub-
lished. The assumptions of these models and their respective goals vary greatly, influencing
both their potential applications and their limitations. Although our model applies very
similar physiological principles, we seek to simulate more macro-level effects.
Arthur C. Guyton is one of the most prominent and early figures to publish circulatory45
system modeling research. He determined that previous models had not incorporated all of
the long-term regulation mechanisms, including the relationship between body fluid volumes
and systemic function through a negative feedback loop [16]. For example, an increase
in arterial pressure is balanced out by a decrease in body fluid volume and venous return.
Guyton focused his studies on exploring the relationship between hypertension and the renal50
system [15], but he did not closely examine organ-organ dynamics. In the future, we hope
to provide mathematical modeling insight on this.
In the Neal & Bassingthwaighte 2007 model, baroreceptor control was included to ac-
count for time-independent cardiac elastance [29]. The model was implemented to predict
hemodynamic responses from acute hemorrhage while validating the outcomes with pig hem-55
orrhage experiments. It most notably differs from our model by the inclusion of baroreceptor
control, coronary circulation, nonlinear resistances for systemic circulation, and ventricular
elastance. However, both of our models share the expression of pressure as a function of the
difference of total blood volume and unstressed volume.
Albanese et al. 2016 model incorporates an in-depth simulation of pulmonary capillary60
blood and alveolar air exchange along with central nervous system regulation mechanisms
[2]. While the flow rate functions resemble the functions that we use, they additionally
incorporate tissue gas exchange flow rates for the major organ systems. They arrange these
organs as parallel circuits; we plan to use a similar method once we are ready to add the
3
major organ systems.65
Ursino & Magosso 2000 assume that the atria have passive compliance and the beating
mechanism of the heart creates active ventricular compliance [46]. This decision prompted
us to consider the atria as insignificant compared to the thick walls and muscular strength
of the ventricles. For our model, the atria do not contract alongside the ventricles.
While previous models incorporate complex mechanisms of long-term regulation and70
establish many nonlinear relationships, we seek to present a more simplified system. Since
the circulatory system will be a part of a network of inter-connected organs at a later time,
a more simplistic model makes the overall organ systems model more manageable.
1.3 Key Cardiac Functionality
The circulatory system relies on a predictable cyclic repetition of beating ventricles to75
pump blood to the rest of the body. Cardiac cycle, which is one complete period of a
heartbeat, is approximately 0.8 seconds long with a rate of 75 beats per minute (bpm) [20].
The normal cardiac output is around 4-7 L/min [27]. The heart contains four flow-control
valves connected to the ventricles. They include the mitral and tricuspid valves, known
together as the atrioventricular (AV) valves, and the aortic and pulmonary valves, known80
together as the semilunar (SL) valves (Figure 2.1). The mitral valve regulates flow from the
left atrium to the left ventricle, the tricuspid valve regulates flow from the right atrium to
the right ventricle, the aortic valve regulates flow from the left ventricle to the aorta, and
the pulmonary valve regulates flow from the right ventricle to the pulmonary artery [20].
Along with the ventricles, the valves operate on their own schedule. The SL valves are85
open for roughly 0.21 seconds and the AV valves are open for 0.46 seconds during a single
cardiac cycle [27]. The opening of the valves is driven by blood pressure gradients between
the ventricle and the blood vessel that the valve is located between. There are also two
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special cases for when both sets of valves are closed. During isovolumetric contraction,
the ventricles contract and ventricular pressure rises for the SL valves to open. During90
isovolumetric relaxation, the ventricles relax and ventricular pressure decreases for the AV
valves to open. In both scenarios, ventricular blood volume is unchanged from the closure
of the valves.
The ventricles eject blood directly following isovolumetric contraction. This blood,
termed stroke volume (SV), is defined as the volume of ejected blood that enters the target95
artery per beat. It is often associated with the rapid discharge of blood into the aorta. The
mathematical formula is given by the difference between ventricular end-diastolic volume
(VEDV) and end-systolic volume (VESV). A UK sudy found the following normal reference
ranges for women: LVEDV = 124 mL, LVESV = 49 mL, RVEDV = 130 mL, and RVESV
= 55 mL. For men, LVEDV = 166 mL, LVESV = 69 mL, RVEDV = 182 mL, and RVESV100
= 85 mL [34]. ”L” stands for left and ”R” stands for right.
The Frank-Starling Law is another important concept, particularly governing the idea
that both ventricles output the same stroke volume. Since both sides of the heart contract
almost simultaneously, cardiac output must be fairly equivalent on both sides of the heart
to ensure that blood is not pooling up in the lungs [12]. The length of the cardiac muscle105
fibers is not the only determinant of ejection force though [7]. Stroke volume is directly
related to preload and afterload. If central venous pressure increases (preload), then the
pressure gradient will drive an increase in blood into the ventricle. The increase in volume
of blood will stretch the muscular fibers of the myocardium and the heart will contract
with greater force, releasing more blood into the aorta. Similarly, greater aortic pressure110
(afterload) decreases the pressure gradient and limits the blood flow out of the ventricle [48].
The next section further elaborates on the role of pressure gradients and other hemodynamic
parameters in mediating blood flow between any two blood vessels.
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1.4 Introduction to Hemodynamics
With numerous fluid dynamic principles available, scientists and mathematicians have115
creatively translated these laws for blood flow in the circulatory system. Jean Leonard
Marie Poiseuille performed scientific experiments to identify the relationship, now known
as Poiseuille’s Law, between length L, viscosity µ, diameter D, the flow rate Q of fluids
through the tube, and the pressure gradient ∆P . Equation (1.1) shows a common derivation





Poiseuille’s Law exhibits how the direction and magnitude of blood flow is dependent on
the pressure exerted in the current location and the pressure exerted in the intended location.
In broad terms, flow rate Q is a function of resistance of a tube R and the difference ∆P
between the pressures entering the tube and leaving the tube. This proportional relationship
has been shown to hold in even the the thinnest compartments in the circulatory system,125






Volume of blood and blood pressure are proportional to each other through a quantity
known as compliance. Homer Warner [47] may have been the first cardiologist to explain that
average ventricular compliance values change from systolic to diastolic phase. Compliance130
can be thought of as the general ”stretchiness” of a blood vessel or ventricle and its ability
to accommodate increasing volumes of blood. The general relationship between compliance,






Blood vessels that have a high compliance are able to accommodate increasing blood
volume without exerting much pressure. On average, venous compliance is 30 times greater135
than arterial compliance [18]. It is essential to maintain a high venous compliance since
the veins carry a large percentage of the total blood volume, and increased venous stiffness
can lead to adverse cardiovascular events such as hypertension [32]. Compliance eventually
decreases as we age and the walls of the blood vessels become hardened.
The equations introduced in this section serve as the framework of our circulatory system140




2.1 Compartment Diagram and Variables
Our circulatory system model includes the four-chambered heart, major blood vessels,145
lungs, and a generic organ as a placeholder for systemic organs. The model compartments
and relevant blood flows are represented with a compartment diagram (Figure 2.1). In order
to simplify the structure of the circulatory system, arterial and venous blood vessels are
grouped into single compartments. These compartments only include the larger vessels with
higher blood pressure, such as the aorta, large arteries, and proximal pulmonary arteries. The150
smaller arterioles and capillaries are included in the lung and generic organ compartments,
where blood pulsation effects greatly diminish from the distribution of blood through these
delicate and highly resistant tubes. This structure allows for the arteries compartment to
reflect aortic blood pressure, the most common metric used by doctors.
The left atrium and right atrium, which contract slightly before their ventricular coun-155
terparts, are placed with the pulmonary veins and systemic veins. Since researchers appear
to use central venous pressure or atrial pressure as the preload mechanism of stroke volume,
it is presumed that the atria have similar parameters as the venous system [29], [7].
8
Figure 2.1: Compartment diagram for the proposed circulatory system model. For every
adjacent pair of compartments i and j, there is a fate function fij that governs the blood
flow from i to j.
In our model, time is the independent variable and the 8 dependent variables depict the
blood volume in each of the 8 compartments. Additionally, we include blood pressure as an160
intermediate variable to reflect the relationship between volume and pressure (Table 2.1).
Change in blood volume dBi
dt
for a compartment i is the difference of the flow rate in and
the flow rate out (Equations (2.1) - (2.8)). With the differential equations now constructed





= f81 − f12 (2.1)
dBpa
dt
= f12 − f23 (2.2)
dBL
dt
= f23 − f34 (2.3)
dBpv
dt
= f34 − f45 (2.4)
dBlv
dt
= f45 − f56 (2.5)
dBa
dt
= f56 − f67 (2.6)
dBorg
dt
= f67 − f78 (2.7)
dBv
dt
= f78 − f81 (2.8)
Symbol Description Units Role
t time min independent
variable



















Table 2.1: Key model components along with their descriptions.
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2.2 Rate Functions
Our choice of rate functions is based, in part, on the following assumptions regarding
back-flow of blood and flow of blood through the organs.
Assumptions170
1. Back-flow of blood resulting from a negative pressure gradient is impossible.
2. Every flow rate is dependent on a blood pressure gradient.
3. Since valves open and close according to the shift in the blood pressure gradient, heart
valves do not explicitly need to be represented by a variable.
Each flow rate function can therefore be equated to the Hagen-Poiseuille Law (Equation175













































The piecewise function ensures that there is no back flow if the pressure gradient is less
than zero. As an example, blood will not flow in the forward or reverse direction between
the right ventricle and pulmonary arteries if Prv 6> Ppa (Equation (2.9)).
Although blood flow is driven by pressure gradients, we want to use blood volume as our180
dependent variable. The expected conservation of total blood volume across all compart-
ments of the model makes it easier to prove the validity of the model. In order to convert
between blood pressure and blood volume measures, we also need the rate functions to be
in terms of blood volume.
2.3 Pressure/Volume Relationships185
The following assumptions are made regarding the pressure/volume relationship for each
compartment.
Assumptions
1. Every compartment, except for the ventricles, has constant compliance and volume
capacity. Although the pressure/volume relationship can take on a nonlinear form at190
volumes very far from the unstressed volume, the relationship is fairly linear under
normal conditions [14, 29]. Furthermore, it is during times of venoconstriction and
venodilation that compliance will shift. This model disregards these mechanisms as
short-term responses to regulate blood flow with the assumption that our patient is
not experiencing adverse cardiovascular events.195
2. Ventricular compliance and volume capacity are highest during diastole and lowest
during systole. During diastole, the pressure stays steady as blood is flowing into the
relaxed ventricles. This increase in surface area directly corresponds to the increase
in volume capacity. During systole, the ventricles contract and shrink, resulting in a
significant build-up of pressure.200
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3. If the total blood volume within a compartment is only made up of unstressed volume
(V̄ ), then the corresponding pressure is calibrated to zero. Unstressed volume does not
contribute to a change in transmural pressure [2].
Equations (2.17) - (2.24) display the pressures Pi of each compartment in terms of volume
capacity V̄i, total blood volume Bi, and compliance Ci. Note that these equations were205























































if Bv > V̄v
0 if otherwise
(2.24)
Modeling nonlinear ventricular compliance or its inversely related counterpart, elastance,
is not entirely novel. In one model, a linear piecewise function for elastance was used to match
the pulsating shape of ventricular pressure [8]. In our model, sine functions for ventricular210
compliance and volume capacity are fit to the cardiac cycle and the ventricular blood volume
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graph. Using sine functions instead of linear functions as the non-constant pieces of these
equations makes certain that it is differentiable at each point in the cardiac cycle.
The parameters of the sine functions are defined (Equations (2.25) - (2.28)). Parameters
a, b, and c are characteristics of the timing of the cycle: a represents the time that the systolic215
period begins, b is the time at which peak pressure is reached during the systolic period,
and c is the time that the systolic period ends. f and s are determined by the frequency of
the beats and the center of the pressure/volume curves, while m and a are the mean values
and the amplitude of the sine curve. mx must be equal to m in order for the constant piece
to intersect perfectly with the sine piece at time c. As a result, both m and mx are the220
maximum volume capacity values. Figure 2.2 shows the simultaneous fluctuations in volume
capacity and compliance from our model.
V̄lv(t) =

m1− a1 ∗ sin(f1 ∗ (T − s1)) if a ≤ T ≤ b





m3− a3 ∗ sin(f1 ∗ (T − s1)) if a ≤ T ≤ b





m5− a5 ∗ sin(f1 ∗ (T − s1)) if a ≤ T ≤ b





m7− a7 ∗ sin(f1 ∗ (T − s1)) if a ≤ T ≤ b




Figure 2.2: Plot of left ventricular unstressed volume and compliance using the above
piece-wise functions.
So, our final model consists of differential equations (DE) (2.1) - (2.8), with each fij
given by Equations (2.9) - (2.16) and each Pk given by Equations (2.17) - (2.24). With the
complete set of equations defined, the differential equations can be solved.225
2.4 Model Analysis
A Mathematica notebook was set up with the model equations and parameter values.
Each compartment has a differential equation within the NDSolve[] function that gives a
solution for total blood volume B as a function of time t (Equations (2.1) - (2.8)). Initial
conditions for blood volume for each compartment and a time range are required as a part230
of this Initial Value Problem (IVP). Initial conditions are based on average values for total
blood volume (Table 2.2).
Blood pressure is also a valuable variable to use when comparing outcomes of the IVP
since we can change between blood volume and blood pressure by Equation (2.17) - (2.24).
Consequently, blood pressure plots change in response to changing the IVP parameters and235
solution.
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2.5 Choosing the Parameters
In total, there are 41 parameters (excluding the initial conditions). They are made up of
compliances and volume capacities, ventricular compliances and volume capacities, and rate
constants. Chapter 3 briefly discusses difficulties in confidently selecting a set of parameter240
values to emulate normal hemodynamic circumstances. There is generally a lack of human
hemodynamic data for compliance, volume capacity, and resistance. Many models have































































Veins 8-12 [40] 3455 [45] 2900 [45] 111.111 [45] 0.00138447
[29]
Table 2.2: Set of hemodynamic values that play a crucial role in choosing model
parameters. Values are from previous reputable mathematical models, animal experiments,
or estimated based on what appears to create a good fit.
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For arteries and veins, parameter values are calculated from many smaller categories245
provided by math models (Table 2.2). Resistances are summed, compliances are averaged,
and total blood volume and capacity are summed in order to calculate values for the larger
compartments in our model. Volumes are summed in order to conserve total blood volume
across the system. Since the chain of these blood vessels can be treated as a series circuit,




they are inversely proportional. The generic organ provided the most flexibility in setting
parameter values because it is not associated with one specific systemic organ. Theoretically,
every organ would have unique parameter values and varying blood flow rates across the
capillaries and tissue. This assumption will be considered as we append the organ systems
to our model in the future.255
Equations (2.29) - (2.49) list the left and right ventricular volume capacity and compliance




m1 = m2 = 71.8 (2.29)
a1 = a2 = 48.1 (2.30)
mx1 = 71.8 (2.31)
m3 = m4 = 103 (2.32)
a3 = a4 = 49.5 (2.33)
mx2 = 103 (2.34)
m5 = m6 = 10.8 (2.35)
a5 = a6 = 10.61 (2.36)
mx3 = 10.8 (2.37)
m7 = m8 = 29.15 (2.38)
a7 = a8 = 27.26 (2.39)
































∗ cardiac period (2.47)






The literature values in Table 2.2 serve as the basis of our model parameters and provide




Our goal is test our model to make sure that the results are consistent with what is already
known about normal circulatory system function. The plots from Section 3.2, 3.3, and 3.4
are from running simulations on our model; they ultimately demonstrate that our model
results are consistent with the literature and our model appears to uphold the principles of265
hemodynamics.
3.1 Assumptions
In order to determine parameter values and run purposeful simulations, a hypothetical
healthy patient is considered with the following assumptions.
Assumptions270
1. The patient is a young and healthy 70 kg male that has normal hemodynamic measures.
Aortic pressure should be in the 80-120 mmHg range and stroke volumes should be
normal.
2. The patient is not undergoing any hemodynamic stress where they would be losing
blood. Although each blood vessel with experience fluctuations in blood volume, the275
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patient’s total blood volume will remain constant.
3.2 Validating Blood Pressure and Valves
Since there is a lot of information regarding normal blood pressure ranges for the ventricles
and major blood vessels, we investigate the changing blood pressures for the pulmonary
system with the right ventricle and systemic system with the left ventricle.280
Every blood vessel downstream of the right ventricle is expected to consistently have
a lower blood pressure than its predecessor (Figure 3.1). The same trend occurs for the
systemic vessels downstream of the left ventricle (Figure 3.2).
We can further look into the functioning of the valves from these figures. Early on
during systole, the right ventricular pressure rises above pulmonary arterial pressure and the285
pulmonary valve opens. After the ventricle contracts and pressure decreases, pressure falls
below the pulmonary arteries and the pulmonary valve will close. The same holds true for
the left ventricular pressure and aortic pressure due to the aortic valve. In addition, it is
observed that the right ventricular pressure falls within 5 - 30 mmHg and left ventricular
pressure ranges from 10-115 mmHg, closely matching the literature. However, the aortic290
pressure is only 80 - 105 mmHg, resulting in a need for better parameter values to increase
the amplitude of the aortic pressure curve.
20
Figure 3.1: Plot of blood pressure for the right ventricles Prv, pulmonary arteries Ppa, lungs
PL, and pulmonary veins Ppv for a single cardiac cycle.
Figure 3.2: Plot of blood pressure for the left ventricles Plv, arteries Pa, generic organ Porg,
and veins Pv for a single cardiac cycle.
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3.3 Validating Total Blood Volume
From the previously stated assumptions, each compartment is expected to display stable
solutions for total blood volume and the sum of these blood volumes will remain constant.295
Figure 3.3 shows that all pulmonary blood vessels and the right ventricle reach equilibrium
volume after approximately 0.12 minutes. While all of vessels experience short bursts of
changing volumes, the volumes appear to have a steady-state equilibrium.
The left ventricle and systemic system plot shows solutions that are stable from the
very beginning (Figure 3.4). Although the the graph appears to show less cyclic changes300
in volumes across the systemic vessels, the graph is highly skewed by the large volume of
the veins. By creating an additional function for the sum of the blood volume in all of the
compartments, we can confirm that the amount of blood circulating in the whole system is
constant.
Figure 3.3: Plot of blood volume for the right ventricles Brv, pulmonary arteries Bpa, lungs
BL, and pulmonary veins Bpv.
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Figure 3.4: Plot of blood volume for the left ventricles Blv, arteries Ba, generic organ Borg,
and veins Bv.
3.4 Validating Stroke Volume305
Now, we determine if the left and right ventricles are ejecting the expected amount of
blood each cardiac cycle. Figure 3.5 reveals that the right ventricle has RV EDV = 170 and
RV ESV = 100 mL for stable cardiac cycles. Then RV SV = 70 mL. While the RV EDV
is very close to the value mentioned in Table 2.2, the RV SV is 15 mL lower than another
source [34]. Since stroke volume is individualistic, we conclude that 70 mL falls within a310
wide range of normal values.
Figure 3.6 indicates that the left ventricle has roughly LV EDV = 120 and LV ESV = 45
mL after stabilizing. As a result, LV SV = 75 mL. The LV EDV is very close to the value
given in Table 2.2, but the values do fall short from another source [34]. Again, we assume
that 75 mL falls with a large normal range for left ventricular stroke volume. In addition,315
the close equality between LV SV and RV SV preserves the Frank-Starling Law from Section
1.3.
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In conclusion, both ventricles eject the expected amount of blood into the pulmonary
arteries and aorta.
Figure 3.5: Plot of blood volume of the right ventricle Brv for three cardiac cycles.
Figure 3.6: Plot of blood volume of the left ventricle Blv for three cardiac cycles.
Now that our model has been proven to accurately simulate blood flow in the circulatory320
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system, we can move forward with assessing our model’s ability to transfer oxygen, drugs,
and other vital substances.
25
Chapter 4
Two Extensions: Oxygen and
Hypertension325
These two extensions describe how our current model could be modified to include the
transfer of oxygen and the delivery of drugs. Future directions for these applications are
explained in the context of our subsequent goal to create a major organ systems model.
4.1 Oxygen Delivery and Consumption
Oxygen is an essential reactant for various functions on the cellular level, including aero-330
bic cellular respiration. Oxygen molecules are bound to haemoglobin found in erythrocytes
(red blood cells), which are distributed across the body following uptake [5]. Oxygen con-
centrations can change based on the binding affinity to haemoglobin and successful uptake of
oxygen by the alveoli, so blood flow alone does not dictate oxygen delivery rates. Equation
(4.1) gives oxygen delivery DO2 in terms of flow rate Q and concentration of arterial oxygen335
CaO2 [35].
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DO2 = Q ∗ CaO2 (4.1)
Concentration of arterial oxygen CaO2 is dependent on concentration of hemoglobin, sat-
uration of arterial oxygen, and partial pressure of arterial oxygen. Oxygen consumption
relies on the difference in oxygen content in the arteries and veins connected to the organ.
Thus, venous oxygen concentration (CvO2) is an additional parameter necessary to calculate340
the concentration gradient across the organ. Equations (4.2) - (4.6) show how VO2 can be
written as a proportion of DO2 through substitution [6].
VO2 = Q ∗ (CaO2 − CvO2) (4.2)
VO2 = DO2 − (Q ∗ CvO2) (4.3)














can be referenced as the extraction ratio E, the fraction of blood that is taken
up by the tissue (Equation (4.7)).
VO2 = DO2 ∗ E (4.7)
Every organ has unique values for regional flow rate, oxygen delivery rate, extraction345
ratio, and consumption. These major differences stem from the unique arteries (i.e. renal
artery for the kidneys and the hepatic artery for the liver) that are connected to the organs.
The difference in circuitry of the organ systems allows for local regulation of blood flow. An
increase in extraction ratio could allow for an organ to maintain constant oxygen consumption
during periods of below-normal delivery rates. In fact, this mechanism happens during350
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intense exercise [37]. The heart, skeletal muscle, and brain have the highest extraction
ratios. The brain can only survive for 3 minutes without an adequate amount of oxygen
available [26].
The critical DO2 represents the oxygen delivery rate for which lower rates have a linear
relationship with oxygen consumption [6]. For values aboveDO2 , the extraction ratio or blood355
flow is adjusted to maintain a constant consumption rate. The heart is the only major organ
known to display a completely dependent relationship between oxygen consumption and
delivery [37]. While the exact pathology of blood flow regulation is unknown, vasodilation
and vasoconstriction are believed to alter the surface area of the arteries and thus adjust
blood flow rates. However, we are limited by our uncertainty in how the body distributes360
oxygen among the vital organs in very extreme hypoxic events [37].
Once our model can successfully simulate oxygen transport dynamics, we can use the
same modeling mechanisms to simulate the transport other important substances (e.g. nu-
trients, waste products, medications) throughout the body. These mechanisms will crucial
for modeling sequential organ failure and sepsis.365
4.2 Evaluation of Hypertension Medications
Hypertension is a condition of elevated blood pressure and antihypertensive medications
are commonly prescribed to treat chronic and acute hypertension [3]. The drugs are classified
according to their target receptor. Diuretics, renin-angiotensin system inhibitors, calcium
channel blockers, and beta-blockers are the most common classes of antihypertensives [49].370
In broad terms, diuretics work to inhibit sodium, chloride, and/or potassium absorption
or reabsorption [30]. As a result, blood volume and cardiac output decrease [49]. Beta block-
ers (BB) block the beta-1 adrenergic receptors, which is activated by the neurotransmitter
norepinephrine. Since norepinephrine is critical for stimulating the heart, the blockage re-
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sults in decreased heart rate, contraction, and ultimately lower cardiac output and blood375
pressure [30].
Calcium channel blockers (CBB) block the entry of of calcium ions into the smooth blood
vessel walls. The net-effect is a decline in force of contraction of these blood vessels, known
as vasodilation [30]. Calcium channel blockers can either act on only the arteries or arteries
and cardiac muscles. The renin-angiotensin system (RAS) is composed of multiple pathways380
and provides the opportunity for different target inhibitors. There are ACE inhibitors,
angiontension rececptor blockers, and renin inhibitors [30]. Since angiontensin II leads to
increased sodium and water retention and vasoconstriction, inhibitory mechanisms will limit
these responses and decrease blood pressure [30].
Most of these drugs are only available for oral administration, but clonidine, a centrally385
acting agonist, became the first antihypertensive drug available as a patch [39]. Transder-
mal delivery has some clear advantages; lack of first-pass metabolism and decreased dose
frequency improve patient compliance and limit gastrointestinal (GI) side effects [24]. The
oral and patch versions of clonidine have been shown to display similar efficacy, but the
patch is associated with more side effects (dry mouth, drowsiness, etc.) [39].390
Other than the characterization of hypertension in a patient and the properties of the
available drugs, genetics and preexisting conditions influence drug response and any adverse
reactions. For example, a kidney disease patient will be recommended to take an ACE
inhibitor and an angiotensin receptor blocker while patients experiencing heart failure or
heart attacks will be told to avoid CCBs [30]. If a patient is not responding to a single class,395
combination therapy is usually administered, with CCBs, BBs, and alpha blockers being the
most common combination [21].
In addition to their unique mechanisms of action (MOA), antihypertensive drugs possess
different pharmacokinetic and pharmacodynamic parameters.
29
4.3 Modeling Pharmacokinetics400
Pharmacokinetics is the science of the absorption, distribution, metabolism, and excretion
of a drug in the body [4]. Some models include the GI system as a compartment [1],
while other models elect to focus on distribution of the drug to the different organs [4].
First-pass metabolism, which is drug metabolism that occurs (due to interactions in the
stomach and liver) prior to entering the systemic circulation, is a major disadvantage of405
drugs taken orally [4]. First-pass metabolism greatly influences the bioavailability, which is
the proportion of drug that enters the bloodstream. For transdermal drugs, proportion of
drug that successfully passes through the dermis and epidermis layers is dependent on the
lipid solubility property of the drug [4].
Figure 4.1 shows a compartment diagram for pharmacokinetics of a drug taken orally.410
This compartment diagram does not apply to other delivery systems, such as transdermal
patches, because it includes the GI system as the uptake location prior to entering the
bloodstream. We were inspired by [1] to include the GI system as a compartment in order
to best demonstrate differences between drugs given their unique bioavailability properties.
Many other models [1], [4] do not include a rate of administration g01, but in our case, we415
need it to schedule the administration of multiple doses.
30
Figure 4.1: Compartment diagram for pharmacokinetics of oral delivery of drugs. g01 is the
administration rate, g10 is the rate of which the drug is metabolized by the GI system and
turned inactive, g12 is the rate of absorption into the bloodstream, and g20 is the rate of
elimination. The kidneys usually excrete water-soluble drug metabolites.
Again, we set up our differential equations for each compartment given the flow rates
in and out (Equation (4.8) - (4.9)). Amount of drug A is the dependent variable measured
for the GI compartment and concentration of the drug C is the dependent variable for BL
compartment. Volume of distribution V D is used to convert amount (mg) to concentration420
(mg/mL) (Equation (4.9)). It represents the volume of a fluid that a drug would need to
be dissolved in to have the same plasma concentration [4]. V D is a characteristic of a drug
that can be often be found on the FDA or drug manufacturer’s website.
dAGI
dt







In Equation (4.10), d is the dose amount (mg) and dt is the time it takes for the drug to
dissolve in the stomach and become available for absorption into the bloodstream. Equation425
(4.11) takes the single dose rate A(t) and schedules multiple doses based on the frequency
of the dose df . The GI will metabolize the (1 − f) proportion of drug prior to it entering












A(t)(t− (j − 1) ∗ df ) (4.11)
g10 = (1− f) ∗ k10 ∗ AGI (4.12)
g12 = k12 ∗ f ∗ AGI (4.13)
g20 = k20 ∗ CBL (4.14)
Table 4.1 lists common pharmacokinetic parameters of a drug that are traditionally
discovered during pre-clinical and clinical trials. Half-life is the amount of time for plasma430
concentration to decrease by 50%, tmax is the time it takes for maximum plasma concentration
to be reached, Cmax is the maximum plasma concentration, and steady-state concentration





Dose (mg) 0.1 (twice a day) [38] 5 (weekly) [44]
Volume of Distribution
(mL)
197000 [44] 197000 [44]
Half-life (hrs) 12-16 [43] 12-16 [44]
tmax (hrs) 1-3 [43] within 3 days [33]
Cmax (ng/mL) 0.2-2 [43] N/A
Bioavailability (%) 70 [43] 60 [44]
Steady-state Concentration
(ng/mL)
0.30-0.35 [23] 0.8 [33]
Table 4.1: Pharmacokinetic parameters for comparison of oral and transdermal delivery
systems of clonidine provided by the brand Catapres.
Each compartment has a differential equation within the NDSolve[] function that solves
for either amount of drug or drug concentration. Plasma concentration curves are graphed435
separately for oral and transdermal clonidine drugs.
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Figure 4.2: Plot of plasma concentration curve (ng/mL) over time (hours) for a 0.1 mg pill
of Catapres given every 10 hours.
Figure 4.3: Plot of plasma concentration curve (ng/mL) over time (hours) for a 5 mg patch
of Catapres replaced every week.
While the clonidine patch does not undergo first-pass metabolism, a bioavailability less
than 100% indicates that some portion of the drug is lost before absorption. This is most
likely due to the lipid solubility characteristic of the drug and inability for the drug to
penetrate the skin and move across the dermis and epidermis layers. We determine that the440
skin can act as the GI compartment presented in Figure 4.1 for transdermal drugs.
Figure 4.3 shows a higher maximum plasma concentration and steady-state concentra-
tion for the clonidine patch than the clonidine pill in Figure 4.2. Since the pill is also
more frequently administered than the patch, a patient will experience more acute fluctua-
33
tions in plasma concentration and potentially varying pharmacological effects. Both plasma445
concentration curves show equilibrium concentrations that meet the expected steady-state
concentrations (Table 4.1).
4.4 Modeling Pharmacodynamics
Pharmacodynamics is the study of how a drug interacts with its target receptor to create
pharmacological effects [4]. For hypertension, the expected response would be a significant450
decrease in blood pressure. Dose-response curves measure the effect of a drug given the dose.
Since we do not want to compare dosages, but rather the long-term effects of each drug, it
would be necessary to have a concentration-response curve for each drug of interest. We
would want to evaluate the decrease in blood pressure given the plasma concentration of the
drug in the body. With this information, we can determine the percent change in parameter455
values that are directly affected by a drug given its MOA. In our model, relevant parameter





While our circulatory system model would benefit from more precise parameter values,
the simulations in Chapter 3 display several parallels with known physiology. Our model
successfully uses the ventricles to pump blood across the blood vessels, lungs, and an organ
for multiple cardiac cycles. We can hypothesize that this model will be able to pump blood
to multiple organs that are connected in a parallel circuit. A new compartment would be465
added for the addition of each major organ system, and new rate functions that connect
the organs to their local arteries and veins would be necessary. As mentioned in Chapter 4,
these regional flow rates dictate delivery of oxygen and it is crucial for each organ’s ability
to regulate regional blood flow.
We conclude that this model can serve as the framework of a multiple organ system470
model to simulate septic infections and sequential organ failure. It could also be worth-
while to further explore the effect of antihypertensive medications with more organ systems
represented. Since the GI system metabolizes drugs and the renal system excretes most
water-soluble drugs and plays a crucial role in the pathology of hypertension [15], the liver
and kidneys would be important additions for drug delivery models. The oral and transder-475
mal pharmacokinetics model could be valuable later on as we integrate treatment options
35
for cardiovascular conditions and organ damage.
In conclusion, our proposed circulatory system model shows great promise as a foundation
for a major organ systems model to examine the net effects of organ dysfunction.
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